| PET Myocardial Fatty-acid Metabolic Imaging With XTR003 Injection and 18F-FDG to Assess Myocardial Viability in Ischemic Cardiomyopathy (NCT07443696) | Sinotau Pharmaceutical Group | 2025-12-18 |
| Comparison of Diagnostic Accuracy Between XTR004 PET MPI and the Composite Index of Quantitative Coronary Angiography (QCA) and Fractional Flow Reserve (FFR) (NCT07439133) | Sinotau Pharmaceutical Group | 2025-11-14 |
| A Clinical Trial Evaluating the Safety and Tolerability, Biodistribution and Radiation Dosimetry, and Pharmacokinetics of Flotufolastat F-18 Injection in Healthy Chinese Adults (NCT07149831) | Sinotau Pharmaceutical Group | 2025-06-07 |
| Diagnostic Efficacy and Safety of Flotufolastat F-18 Injection in Subjects With Biochemical Recurrence of Prostate Cancer (NCT07115277) | Sinotau Pharmaceutical Group | 2025-03-14 |
| Comparative Imaging of XTR004 PET and MIBI SPECT in Borderline Coronary Stenosis (NCT07187895) | Sinotau Pharmaceutical Group | 2024-12-19 |
| Analysis of 18F-XTR006 PET Imaging in Cognitively Normal Subjects, and Patients With MCI and AD (NCT07115238) | Sinotau Pharmaceutical Group | 2024-11-20 |
| A Clinical Study of Lutetium[177Lu] Oxodotreotide Injection in Patients With Advanced Neuroendocrine Neoplasms (NCT06398444) | Sinotau Pharmaceutical Group | 2024-06-11 |
| Study of [177Lu] Lu-XT033 Injection in Patients With Metastatic Prostate Cancer (NCT06081686) | Sinotau Pharmaceutical Group | 2023-09-13 |
| A Study to Evaluate XTR006 in Chinese Volunteers (NCT06151795) | Sinotau Pharmaceutical Group | 2023-06-12 |
| Analysis of XTR006 PET Imaging in Non-cognitively Impaired Subjects, MCI Due toAD, and Mild to Moderate AD Subjects (NCT06151808) | Sinotau Pharmaceutical Group | 2022-09-01 |
| A Study Comparing Treatment With Lutetium[177Lu] Oxodotreotide Injection to Octreotide LAR in Patients With GEP-NETs (NCT05459844) | Sinotau Pharmaceutical Group | 2022-08-31 |
| Evaluation of XTR004 as a Novel 18F-labeled PET MPI Tracer in Diagnosis of Known or Suspected CAD (NCT05885841) | Sinotau Pharmaceutical Group | 2022-02-15 |
| XTR003 PET Radiotracer for the Detection of Viable Myocardium (NCT05885854) | Sinotau Pharmaceutical Group | 2021-12-15 |
| Clinical Study on PET Imaging, Distribution and PK of 89Zr-CD147 in Patients With Solid Tumors (NCT04841421) | Sinotau Pharmaceutical Group | 2021-05-01 |
| A Phase I Study to Evaluate XTR003 in Healthy Chinese Volunteers (NCT05136391) | Sinotau Pharmaceutical Group | 2021-03-29 |
| A Study of XTR004 Radiotracer in Healthy Volunteers (NCT05195879) | Sinotau Pharmaceutical Group | 2021-03-23 |
| A Bridging Study on Efficacy and Safety of [18F]Florbetaben PET for Diagnosis of Alzheimer Disease Subjects in Chinese Population (NCT05527288) | Sinotau Pharmaceutical Group | 2021-01-28 |